Vectans Pharma

Vectans Pharma

Fabrication de produits pharmaceutiques

Saint-Cloud, Île-de-France 2 103 abonnés

A New Therapeutic Horizon

À propos

Vectans Pharma is an international company headquartered in France, dedicated to the optimization of existing treatments and the development of innovative products through its Lauriad® Platform. With a focus on anti-infective drugs and supportive care, Vectans conceives and develops “Best-in-disease” treatments . Created in 2015 , Vectans Pharma’s ambition is to become an healthcare leading player by coupling innovation to patient’s needs. The company’s teams have the key competencies required to identify, develop and register drugs in Europe, Asia, North and South America.

Secteur
Fabrication de produits pharmaceutiques
Taille de l’entreprise
11-50 employés
Siège social
Saint-Cloud, Île-de-France
Type
Société civile/Société commerciale/Autres types de sociétés
Fondée en
2015
Domaines
Acquisition, In-Licensing, Market Access, Oral Pathologies et Oral Mucosa Targeted Therapeutics

Lieux

Employés chez Vectans Pharma

Nouvelles

  • 🤔 According to the World Health Organization, 50% of treatments prescribed worldwide are poorly followed by the patients concerned. 💡 Maybe improving therapeutic compliance through optimized galenic be one of the solutions. 👉 For you, which, among these pharmaceutical forms, is your favorite ?

    Ce contenu n’est pas disponible ici

    Accédez à ce contenu et plus encore dans l’application LinkedIn

  • Voir la page d’organisation pour Vectans Pharma, visuel

    2 103  abonnés

    💊 Patient perceptions of pharmaceutical therapy can be significantly impacted by variations in galenic. ✔️ Improving the acceptability of dosage forms for patients is of great interest for improving adherence. ➡️ According to the French Candidoscope Study*, it appears that the mucoadhesion route of administration would be the most efficient one for 88,2% of patients. 🔥 Lauriad® Technology is a mucoadhesive tablet which allows a significant reduction in dosage and a limitation of drug intakes, which can go as far as a single dose, for better therapeutic compliance. 👉 To learn more about it: https://lnkd.in/d3MVBp77 * Prevalence and Treatment Management of Oropharyngeal Candidiasis in Cancer Patients: Results of the French Candidoscope Study- 2011

    • Aucune description alternative pour cette image
  • Voir la page d’organisation pour Vectans Pharma, visuel

    2 103  abonnés

    🔎 Several studies on the burden of skin diseases have been performed in patients to evaluate the impact on quality of life and stigmatization. ➡️ 88,1% of participants considered their skin disease as embarrassing in personal life and 83% in work life. 📅 On this National Herpes Day, let’s highlight herpes labialis which is considered as one of the 10 most stigmatizing skin diseases. According to a national study conducted by Vectans Pharma in collaboration with the “Quotidien du Médecin”, 44% of patients suffering from cold sores experience a feeling of stigmatization.  ❔ Unfortunately, because they are less often life-threatening, skin diseases are currently largely forgotten by public health. 👉 To learn more about these studies: https://lnkd.in/efMaCQFw https://lnkd.in/ePKYMMTD

    • Aucune description alternative pour cette image
  • Voir la page d’organisation pour Vectans Pharma, visuel

    2 103  abonnés

    ❗️ The World Health Organization estimated that the annual cost of drug therapy noncompliance in Europe was 125 billion of euros, included costs for avoidable hospitalization, nursing home admissions, and early deaths. 📢 It's time to highlight and encourage medical innovations that improve patient compliance. ↪️ “The patient’s survival and quality of life depend on safe and effective treatments that rely on patient-centered pharmaceutical development, where drug products fit the patient’s characteristics and needs*.” 🔥Lauriad® is conceived to optimize medication compliance by a targeted action at the site of infection, releasing an early, effective and prolonged concentration of an active substance, thus enabling a limitation of drug taking. *Oromucosal products – Market landscape and innovative technologies: A review - 2022  👉To know more about Lauriad® technology: https://lnkd.in/d3MVBp77

    • Aucune description alternative pour cette image
  • Voir la page d’organisation pour Vectans Pharma, visuel

    2 103  abonnés

    💊 Wondering what could be the power of this small tablet? 🎯 Targeted efficacy, right on the infection site📌while limiting patient’s exposure. ❓How? ↪️ By releasing an early effective and prolonged concentration of API, thus avoiding the first-pass hepatic effect. 👉 Resulting in: ↪️ Protecting the patient from useless drug’s exposure. 💪 Small but powerful, Lauriad® Technology innoves for enhancement of patient’s compliance 🔥 #Compliance #QualityOfLife #BestInDisease #Comfort

    • Aucune description alternative pour cette image
  • Voir la page d’organisation pour Vectans Pharma, visuel

    2 103  abonnés

    👉 Adhesion to the gum in less than 20 seconds for a drug diffusion over more than 12 hours at the site of infection 🎯  ✔️ Targeted action  ✔️ Early effective and prolonged concentration of API  ✔️ Avoids the first-pass hepatic effect  ✔️ Limits drug interactive and adverse events 🔥 That’s what make Lauriad® Technology a unique galenic. Want to learn more about it ?  👇 https://lnkd.in/dG5ATfvu #Compliance #QualityOfLife #BestInDisease #Comfort

  • Voir la page d’organisation pour Vectans Pharma, visuel

    2 103  abonnés

    💊 Anti-herpetic drugs as a possible therapy in Alzheimer’s Disease? 🔹According to the World Health Organization, more than 55 million people had dementia in 2023. 🔹Alzheimer’s Disease is the most common form of dementia, causing up to 70% of dementia cases. 🔹A recent study highlights that there is evidence indicating a role of herpes simplex virus (HSV) infection in Alzheimer’s Disease development. 💡These findings suggest specific anti-herpetic molecules as possible treatments to slow or stop Alzheimer’s Disease progression, especially in those patients with a documented history of recurrent HSV-1 infection. To know more about the link between Alzheimer’s Disease and Herpes Simplex virus 👇 https://lnkd.in/evedKkbb

    • Aucune description alternative pour cette image
  • Voir la page d’organisation pour Vectans Pharma, visuel

    2 103  abonnés

    🌍 Vectans at CPHI Milan 2024: A Hub of Innovation and Opportunity 👉 We were thrilled to participate in CPHI Milan from October 8th to 10th, three days filled with dynamic exchanges, innovative ideas, and collaborations. 💊 The event provided a unique platform to connect with leading skateholders across the pharmaceutical industry. 🔥 At Vectans, we are excited about the promising opportunities ahead, fueled by the connections we’ve established during these days. 🙏 Thank you to all partners and industry leaders we had the chance to meet. 🚀 Here’s to new ventures, collaborations, and future success! #CPHI2024 #PharmaInnovation #BusinessOpportunities #Vectans #Partnerships

    • Aucune description alternative pour cette image
  • Voir la page d’organisation pour Vectans Pharma, visuel

    2 103  abonnés

    ❤️Agir au cœur de l’affection. 💊Qu’est ce qui fait de Lauriad® un comprimé muco-adhésif unique? 🔥Plus de 12h de diffusion du médicament permettant une pression continue sur l’agent pathogène.   ✔️Limitation des doses ✔️Amélioration de l’observance ✔️Amélioration des résultats thérapeutiques ✔️Écologie des prises 🎯 Lauriad® agit au cœur de la maladie avec un dosage optimisé.  👉 https://lnkd.in/d_kNXj5s #Patients #Innovation #Lauriad

    • Aucune description alternative pour cette image
  • Voir la page d’organisation pour Vectans Pharma, visuel

    2 103  abonnés

    💊 Pour que chaque patient bénéficie du traitement dont il a besoin. 🔹Assurer la qualité, la sécurité et l’accessibilité des médicaments, tels sont les engagements de l’Ordre national des pharmaciens et de l’ANSM Agence nationale de sécurité du médicament et des produits de santé envers les patients. 🔹Pour cela, une charte de bonnes pratiques a été adoptée par l’ensemble de la chaine pharmaceutique afin de limiter autant que possible les interruptions de traitement, répondant ainsi à l’enjeu de santé publique que représente la lutte contre les tensions d’approvisionnement. 🔹 Hier, avait lieu la Journée Mondiale des Pharmaciens. En cette occasion, soulignons le dévouement de ces professionnels de santé afin de garantir au mieux le bien-être des patients. 👉Pour en savoir plus sur la charte: https://lnkd.in/e2CR6ntz #JournéeMondialeDuPharmacien #Patient #Observance

    • Aucune description alternative pour cette image

Pages similaires